TORONTO, Feb. 21, 2018 -- Penfund, an independent provider of junior capital to middle market companies in the United States and Canada, announced today the completion of an investment in CBI Health Group (“CBI”), a portfolio company of OMERS Private Equity (“OPE”).
Penfund Capital Fund V (the “Fund”) provided a C$55.0 million lead order for a new C$70.0 million subordinated credit facility to support a dividend recapitalization of CBI. Penfund also acted as sole underwriter and agent of the subordinated credit facility. Jeremy Thompson, a partner at Penfund, stated, “We are delighted to be able to support OMERS again and are excited to partner with CBI as they continue to execute their growth strategy.”
About CBI Health Group
Headquartered in Toronto, Ontario, CBI is a leading national provider of home health and outpatient rehab services in Canada. From over 250 facilities, CBI provides services from a dedicated team of more than 12,000 that includes physiotherapists, occupational therapists, registered massage therapists, kinesiologists, chiropractors, speech-language pathologists, psychologists, physicians, nurses, caregivers, dieticians and behaviour therapists. CBI’s expanding transitional and residential community care network now numbers more than 100 homes nationwide.
Website: www.cbi.ca
About OMERS Private Equity
OMERS Private Equity invests globally in private equity assets on behalf of the OMERS pension plan. Investments are aimed at generating strong returns to help deliver secure and sustainable pensions to OMERS members. OMERS Private Equity has offices in Toronto, New York, and London. OMERS is one of Canada’s largest pension funds with net assets of C$85 billion.
Website: www.omersprivatemarkets.com
About Penfund
Penfund is a leading provider of junior capital to middle market companies throughout North America. The firm is owned by its management team and is currently investing its most recently established fund, Penfund Capital Fund V. Penfund manages funds sourced from pension funds, insurance companies, banks, family offices and high-net-worth individuals and has invested more than C$3 billion in over 225 companies since its establishment in 1979. Assets and capital under management exceed C$1.1 billion.
Website: www.penfund.com
For further information, please contact:
| Penfund Jeremy Thompson Partner (416) 645-3790 [email protected] | Penfund Adam Breslin Partner (416) 645-3796 [email protected] | Penfund Nicole Fich Partner (416) 645-3791 [email protected] |


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
ADNOC Gas Targets Up to $4B Profit in 2026
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 



